Medicine and Dentistry
Patient
100%
Therapeutic Procedure
92%
Neoplasm
77%
Neurofibromatosis Type II
45%
Young Adult
43%
Malignant Neoplasm
41%
Medulloblastoma
40%
Child
39%
Survival
34%
Radiation Therapy
32%
Vestibular Schwannoma
31%
Diagnosis
31%
Oral Mucositis
30%
Cancer in Young Adults
29%
Inpatient
28%
Adolescent
24%
Bevacizumab
23%
Age
22%
Follow up
21%
Childhood
19%
Mucositis
18%
Patient with Cancer
18%
Primitive Neuroectodermal Tumor
18%
Clinical Trial
17%
Adult
15%
Chemotherapy
15%
Diseases
15%
Cancer
14%
Molecular Profiling
13%
Sarcoma
13%
Pain
13%
Analysis
12%
Quality of Life
12%
Benign Tumor
12%
Schwannomatosis
12%
COVID-19
12%
Evaluation Study
12%
Side Effect
12%
Association
11%
Incidence
11%
Pediatrics
10%
Development
10%
Acute Lymphoblastic Leukemia
10%
Cells
10%
Glioblastoma
9%
Cancer Registry
9%
Patient-Controlled Analgesia
9%
Health
9%
Neurinoma
9%
Cancer Therapy
9%
Nursing and Health Professions
Malignant Neoplasm
43%
Oral Mucositis
42%
Patient with Cancer
31%
Young Adult
26%
Confidence Interval
22%
Patient
21%
Mucosa Inflammation
21%
Adult
17%
Cancer Therapy
17%
Quality of Life
15%
Pain
14%
Cryotherapy
13%
Evaluation Study
13%
Inpatient
13%
Side Effect
12%
Diseases
12%
Placebo
12%
Bevacizumab
12%
Neurofibromatosis Type 2
12%
Chemotherapy
12%
Control
12%
Fatigue
11%
Child
10%
Patient Controlled Analgesia
9%
Radiotherapy
8%
Central Nervous System Tumor
7%
Follow up
7%
Continuous Infusion
7%
Brain Tumor
7%
Cochrane Library
6%
Lymphoma
6%
Patient-Reported Outcome
6%
Cancer Survival
6%
Laser
6%
Acoustic Neuroma
6%
Young People
6%
Prescription
6%
Cancer Research
6%
Cancer Prognosis
6%
Obstetric Delivery
6%
Childhood Cancer
6%
Growth Factor
6%
Cancer Mortality
6%
Clinical Practice
6%
Cancer Registry
6%
Thrush
6%
Benchmarking
6%
Mortality Rate
6%
Toxicity
6%
Measurement
6%
